- Report
- July 2024
- 109 Pages
North America
From €3064EUR$3,450USD£2,660GBP
- Report
- January 2024
- 199 Pages
Global
From €3952EUR$4,450USD£3,432GBP
- Report
- January 2023
- 156 Pages
Europe
From €3064EUR$3,450USD£2,660GBP
- Report
- January 2023
- 166 Pages
Asia Pacific
From €3064EUR$3,450USD£2,660GBP
- Report
- January 2023
- 135 Pages
Middle East, Africa
From €3064EUR$3,450USD£2,660GBP
- Report
- January 2023
- 132 Pages
From €3064EUR$3,450USD£2,660GBP
- Report
- January 2023
- 127 Pages
North America
From €3064EUR$3,450USD£2,660GBP
- Report
- August 2022
- 104 Pages
From €3064EUR$3,450USD£2,660GBP
- Report
- August 2023
- 79 Pages
Global
From €8876EUR$9,995USD£7,708GBP
- Report
- October 2025
- 80 Pages
Kuwait
From €4307EUR$4,850USD£3,740GBP
- Report
- September 2025
- 96 Pages
Germany
From €4307EUR$4,850USD£3,740GBP
- Report
- January 2025
- 230 Pages
United States
From €3108EUR$3,500USD£2,699GBP
- Report
- July 2024
- 187 Pages
China
From €1599EUR$1,800USD£1,388GBP
- Report
- July 2024
- 326 Pages
China
From €3552EUR$4,000USD£3,085GBP
- Report
- July 2024
- 90 Pages
China
From €1599EUR$1,800USD£1,388GBP
- Report
- September 2023
- 114 Pages
Global
From €2620EUR$2,950USD£2,275GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3064EUR$3,450USD£2,660GBP
- Report
- September 2023
- 101 Pages
North America
From €2620EUR$2,950USD£2,275GBP
- Report
- September 2023
- 194 Pages
Global
From €4396EUR$4,950USD£3,817GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2620EUR$2,950USD£2,275GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more